Latest Market Development News

Cedar Woods Properties has raised its FY26 net profit guidance to 15% growth, driven by a surge in presales hitting a record $763 million. The company’s strong pipeline and strategic acquisitions position it well amid a tight housing market.

Hazer Group has made significant strides in commercialising its methane pyrolysis technology, advancing key partnerships and strengthening its intellectual property portfolio amid a tightening global graphite market.

Botanix Pharmaceuticals reports a strong start to FY26 with a 50% surge in Sofdra prescriptions and a 65% rise in net revenue, underpinned by a larger sales team and operational efficiencies.

Aspen Group has upgraded its FY26 pre-tax earnings guidance by 6%, driven by strong rental income growth and development profits amid Australia's acute housing shortage. The company also announces a strategic acquisition of a new Sydney headquarters.

Kinetiko Energy and FFS Refiners have formalised a joint development agreement to co-develop a pilot LNG plant at Brakfontein, marking a significant step in South Africa’s energy transition. The initial phase involves co-funded drilling and gas testing with plans to scale LNG production substantially.

NexGen Energy has expanded its Australian equity offering to AUD 600 million alongside a concurrent C$400 million North American deal, aiming to accelerate development of its flagship Rook I uranium project.

CONNEQT Health has raised $2 million through a convertible note facility with a director-owned entity, providing fresh capital to support its growth plans. Shareholder approval will be key to unlocking the full benefits of this funding.

Reef Casino Trust (ASX, RCT) has received a recommended off-market takeover offer from Iris Cairns Property Pty Ltd at $3.87 per unit, representing a significant premium over recent trading prices. The independent expert affirms the offer as fair and reasonable, with major unitholders supporting the bid subject to regulatory approvals.

Eagle Mountain Mining Limited has dismissed any undisclosed price-sensitive information following a sharp rise in its share price, attributing the movement to external market events and ongoing strategic negotiations.

Orthocell’s nerve repair device Remplir is being adopted in Australia for nerve-sparing prostate cancer surgeries, aiming to reduce erectile dysfunction and urinary incontinence post-operation. This development could significantly expand Remplir’s market reach globally.

360 Capital Mortgage REIT (ASX – TCF) has announced a non-renounceable 1-for-1 entitlement offer to raise approximately $45.2 million, aiming to expand its senior loan investments secured by Australian real estate. The offer includes an oversubscription facility and a shortfall offer targeting wholesale and institutional investors.

Advanced Braking Technology (ABT) reported robust FY25 financial results marked by revenue growth and improved profitability, while advancing its strategic roadmap focused on mining safety innovations and global market expansion.